- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
FDA clears SMV’s coincidence detection
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and
Nuclear medicine vendor SMV America has received 510(k) clearance from the Food and Drug Administration for its Volumetric Coincidence Reconstruction (VCR) technique for its Vision FX-80 gamma camera. SMV, of Twinsburg, OH, joins ADAC Laboratories and Picker International in the group of vendors that have 510(k) clearance for a coincidence-detection technique.
In other SMV America news, the company reported record growth in both orders and product sales for the fourth quarter of 1996, although as a private company it did not release specific dollar figures. The company said that camera and computer orders were up 189%, and shipment revenues increased 64% compared with the same period the year before. For the year, SMV said that product revenues grew by 30% and orders doubled.
SMV America ended the year with a 15.5% market share and a large backlog, the company said, while SMV International, its sister company, saw its market share in Europe expand to 25%.
CT Study Reveals Key Indicators for Angiolymphatic Invasion in Non-Small Cell Lung Cancer
January 15th 2025In computed tomography (CT) scans for patients with solid non-small cell lung cancer (NSCLC) < 30 mm, emerging research suggests the lollipop sign is associated with a greater than fourfold likelihood of angiolymphatic invasion.
New CT and MRI Research Shows Link Between LR-M Lesions and Rapid Progression of Early-Stage HCC
January 2nd 2025Seventy percent of LR-M hepatocellular carcinoma (HCC) cases were associated with rapid growth in comparison to 12.5 percent of LR-4 HCCs and 28.5 percent of LR-4 HCCs, according to a new study.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can AI Facilitate Single-Phase CT Acquisition for COPD Diagnosis and Staging?
December 12th 2024The authors of a new study found that deep learning assessment of single-phase CT scans provides comparable within-one stage accuracies to multiphase CT for detecting and staging chronic obstructive pulmonary disease (COPD).
Study Shows Merits of CTA-Derived Quantitative Flow Ratio in Predicting MACE
December 11th 2024For patients with suspected or known coronary artery disease (CAD) without percutaneous coronary intervention (PCI), researchers found that those with a normal CTA-derived quantitative flow ratio (CT-QFR) had a 22 percent higher MACE-free survival rate.
